ANIK
Anika Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$14.20
-0.10 ▼ -0.70%
🌙 3월 13일 4:10 PM ET (한국 3/14 05:10)
$14.20
+0.00 +0.00%
| Index | RUT | P/E | - | EPS (ttm) | -0.76 | Insider Own | 3.94% | Shs Outstand | 0.01B | Perf Week | 0.57% |
| Market Cap | 0.19B | Forward P/E | 63.11 | EPS next Y | 4600% | Insider Trans | - | Shs Float | 0.01B | Perf Month | 38.54% |
| Enterprise Value | 0.16B | PEG | 0.93 | EPS next Q | -0.07 | Inst Own | 92.19% | Short Float | 5.69% | Perf Quarter | 47.3% |
| Income | -0.01B | P/S | 1.69 | EPS this Y | -104.55% | Inst Trans | 0.22% | Short Ratio | 4.75 | Perf Half Y | 64.54% |
| Sales | 0.11B | P/B | 1.37 | EPS next 5Y | 67.83% | ROA | -4.77% | Short Interest | 0.73M | Perf YTD | 47.76% |
| Book/sh | 10.33 | P/C | 3.31 | EPS past 3/5Y | 9.4% 14.76% | ROE | -6.71% | 52W High | -16.96% ($17.10) | Perf Year | -6.64% |
| Cash/sh | 4.29 | P/FCF | 43.64 | Sales past 3/5Y | -10.28% -2.86% | ROIC | -6.49% | 52W Low | 80.43% ($7.87) | Perf 3Y | -45.49% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 80.25% | Gross Margin | 56.56% | Volatility(W/M) | 4.6% 4.98% | Perf 5Y | -61.69% |
| Dividend TTM | - | EV/Sales | 1.41 | Sales Y/Y TTM | -25.68% | Oper. Margin | -9.8% | ATR (14) | 0.61 | Perf 10Y | -68.18% |
| Dividend Ex-Date | - | Quick Ratio | 3.86 | EPS Q/Q | 101.33% | Profit Margin | -9.64% | RSI (14) | 71.44 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.72 | Sales Q/Q | 0.04% | SMA20 | 10.91% ($12.8) | Beta | 0.29 | Target Price | $17 |
| Payout | - | Debt/Eq | 0.18 | Earnings | 2000000 | SMA50 | 30.05% ($10.92) | Rel Volume | 0.6 | Prev Close | $14.3 |
| Employees | 235 | LT Debt/Eq | 0.17 | EPS/Sales Surpr. | 348% 6.03% | SMA200 | 40.8% ($10.09) | Avg Volume(3M) | 0.15M | Price | $14.2 |
| IPO | 1993/5/3 | Option/Short | Yes/Yes | Trades | 2362 | Volume | 92,938 | Change | -0.7% |
뉴스 로딩 중...